Black women with TNBC show distinct immune profiles, including higher sTILs and lymphocyte counts, potentially linked to ...

Briumvi (ublituximab) has been approved by NICE (National Institute for Health and Care Excellence) for people with active relapsing remitting multiple sclerosis. In England and Wales, NICE has ...

Brain Cancer Canada is excited to announce a $50,000 grant awarded to Dr. Shawn Beug, Scientist at the Children’s Hospital of ...

Rising blood levels of inflammatory marker neutrophil-to-lymphocyte ratio are linked to poorer outcomes with chronic kidney ...

When conflict becomes a recurring pattern, it shifts from occasional stress to chronic strain on the body. The stress builds ...

Interleukin-2 (IL-2) is a well-known cytokine that plays a crucial role in stimulating immune cells, including natural killer (NK) cells and cytotoxic T cells. It has been studied as an immunotherapy ...

Johnson & Johnson today announced new frontline data featuring TECVAYLI® (teclistamab-cqyv) from two investigational studies in patients with newly diagnosed multiple myeloma (NDMM) in induction and ...

Renowned Zimbabwean singer Admire Sanyanga Sibanda, popularly known as Chief Hwenje, is on the path to recovery after ...

The results of two important lymphoma studies led by experts at Roswell Park will be presented during oral abstract sessions this morning at the 66th annual meeting of the American Society of ...

Emerging research findings presented during the 66th American Society of Hematology (ASH) Annual Meeting and Exposition highlight opportunities to improve health outcomes and quality of life for women ...

Medically reviewed by Doru Paul, MD Leukemia is a cancer that changes blood cells. It usually develops in the bone marrow, ...

SPANISH scientists have found a remarkably simple treatment for cancer- aspirin.  Young Spanish scientists have discovered a ...